MOLINDONE, молиндон موليندون 吗茚酮

It’s only fair to share… MOLINDONE C16H24N2O2,, 276.374 SPN 810,  SPN 801M, AFX 2201 cas 15622-65-8 hcl Molindone is used for the management of the manifestations of psychotic disorders. Schizophrenia молиндон موليندون 吗茚酮 (±)-Molindone 2376 3-Ethyl-2-methyl-5-(4-morpholinylmethyl)-1,5,6,7-tetrahydro-4H-indol-4-one [ACD/IUPAC Name] 3-Ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydro-4H-indol-4-one 4H-Indol-4-one, 3-ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)- 7416-34-4 [RN] RT3Y3QMF8N UNII:RT3Y3QMF8N Supernus Pharmaceuticals , under license from Afecta Pharmaceuticals , is developing molindone …

TILDACERFONT

It’s only fair to share… TILDACERFONT Synonyms: Tildacerfont 1014983-00-6 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-7-(1-ethyl-propyl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine 7-(1-ethyl-propyl)-3-(4-chloro-2-morpholin-4-yl-thiazol-5-yl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine MW/ MF 420 g/mol/ C20H26ClN5OS Originator Spruce Biosciences Class2 ring heterocyclic compounds; Morpholines; Pyrazoles; Pyrimidines; Small molecules; Thiazoles Mechanism of Action Corticotropin receptor antagonists Orphan Drug Status Yes – Congenital adrenal hyperplasia New Molecular Entity Yes Phase II Congenital adrenal hyperplasia 09 Jul 2020 Spruce Biosciences initiates a phase II trial …

SULCARDINE SULPHATE

It’s only fair to share… sulcardine, HBI-3000 B 87823 Molecular FormulaC24H33N3O4S Average mass459.602 Da N-[[4-hydroxy-3,5-bis(pyrrolidin-1-ylmethyl)phenyl]methyl]-4-methoxybenzenesulfonamide Benzenesulfonamide, N-[[4-hydroxy-3,5-bis(1-pyrrolidinylmethyl)phenyl]methyl]-4-methoxy- N-[4-Hydroxy-3,5-bis(1-pyrrolidinylmethyl)benzyl]-4-methoxybenzenesulfonamide 343935-60-4 [RN] heart arrhythmia CAS No. : 343935-61-5 (Sulcardine sulfate) Synonyms: B-87823; HBI-3000; B87823; HBI3000; B 87823; HBI 3000;N-(4-hydroxy-3,5-bis(pyrrolidin-1-ylmethyl)benzyl)-4-methoxybenzenesulfonamide sulfate Molecular Formula: C24H35N3O8S2 Molecular Weight: 557.67 Originator Jiangsu Furui Pharmaceuticals; Shanghai Institute of Materia Medica Developer HUYA Bioscience International; Jiangsu Furui Pharmaceuticals Class Antiarrhythmics; …

Diquafosol

It’s only fair to share… Diquafosol Molecular FormulaC18H26N4O23P4 Average mass790.307 Da {Oxybis[(hydroxyphosphoryl)oxy]}bis[hydrogéno(phosphonate)] de bis{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-3,4-dihydroxytétrahydro-2-furanyl]méthyle} 59985-21-6 [RN] 7828VC80FJ 8326 Bis{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-3,4-dihydroxytetrahydro-2-furanyl]methyl} {oxybis[(hydroxyphosphoryl)oxy]}bis[hydrogen (phosphonate)] Diquafosol tetrasodium Molecular FormulaC18H22N4Na4O23P4 Average mass878.234 Da 1) uridine, 5′-(pentahydrogen tetraphosphate), P”’->5′-ester with uridine, tetrasodium salt 211427-08-6[RN] Diquafosol tetrasodium[USAN] uridine(5′)tetraphospho(5′)uridine tetrasodium salt Diquafosol tetrasodium (USAN) INS365 P1,P4-Diuridine 5′-tetraphosphate tetrasodium salt Prolacria U2P4 UNII:X8T9SBH9LL INS-365; DE-089; KPY-998 Title: Diquafosol CAS …

BAY 1895344

It’s only fair to share… BAY 1895344 1876467-74-1 (free base) (R)-3-methyl-4-(4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-1,7-naphthyridin-2-yl)morpholine, monohydrochloride BAY-1895344 Molecular Weight 411.89 Formula C₂₀H₂₂ClN₇O   BAY-1895344 (hydrochloride) 1876467-74-1 1876467-74-1(free base) s8666, CCG-268786, CS-7574, HY-101566A BAY-1895344 hydrochloride is a potent, orally available and selective ATR inhibitor, with IC50 of 7 nM. Anti-tumor activity. NMR https://file.selleckchem.com/downloads/nmr/S866603-BAY-1895344-hnmr-selleck.pdf   Biological Activity In vitro, BAY 1895344 was shown to be a very potent and highly …

MK 5204

It’s only fair to share… MK 5204 CAS No: 1207751-75-4 Product Code: BM178545  (1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-20-(5-carbamoyl-1,2,4-triazol-1-yl)-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid MF: C40H65N5O5 MW: 696g/mol MW 695.97 C40 H65 N5 O5 PAPER https://www.sciencedirect.com/science/article/abs/pii/S0960894X20304686 Abstract Our previously reported efforts to produce an orally active β-1,3-glucan synthesis inhibitor through the semi-synthetic modification of enfumafungin focused on replacing the C2 acetoxy moiety with an aminotetrazole and …

SELGANTOLIMOD

It’s only fair to share… SELGANTOLIMOD GS 9688 RN: 2004677-13-6 UNII: RM4GJT3SMQ Molecular Formula, C14-H20-F-N5-O, Molecular Weight, 293.344 1-Hexanol, 2-((2-amino-7-fluoropyrido(3,2-d)pyrimidin-4-yl)amino)-2-methyl-, (2R)- (2R)-2-((2-Amino-7-fluoropyrido(3,2-d)pyrimidin-4-yl)amino)-2-methylhexan-1-ol Discovery of GS–9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B Journal of Medicinal Chemistry, Articles ASAP (Drug Annotation) Publication Date (Web):May 14, 2020DOI: 10.1021/acs.jmedchem.0c00100 https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.0c00100/suppl_file/jm0c00100_si_002.pd PATENTS Patent ID …

Favipiravir, ファビピラビル

It’s only fair to share… FAVIPIRAVIR FAVIPIRAVIR Toyama (Originator) RNA-Directed RNA Polymerase (NS5B) Inhibitors Chemical Formula: C5H4FN3O2 CAS #: 259793-96-9 Molecular Weight: 157.1 ANTI-INFLUENZA COMPOUND clinical trials  http://clinicaltrials.gov/search/intervention=Favipiravir Chemical Name: 6-fluoro-3-hydroxy-2-pyrazinecarboxamide Synonyms: T-705, T705, Favipiravir Molecular FormulaC5H4FN3O2 Average mass157.103 Da 259793-96-9 [RN] 2-Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo- 6-Fluoro-3-hydroxypyrazine-2-carboxamide 6-Fluoro-3-oxo-3,4-dihydro-2-pyrazinecarboxamide 8916 Avigan ファビピラビル Favipiravir 6-Fluoro-3-hydroxypyrazine-2-carboxamide C5H4FN3O2 : 157.1 [259793-96-9] https://www.pmda.go.jp/files/000210319.pdf The drug …

Camostat Mesilate, カモスタットメシル酸塩 日局収載

It’s only fair to share… Camostat Molecular FormulaC20H22N4O5 Average mass398.413 Da 4-[[4-[(Aminoiminomethyl)amino]benzoyl]oxy]benzeneacetic Acid 2-(Dimethylamino)-2-oxoethyl Ester 4-{2-[2-(Dimethylamino)-2-oxoethoxy]-2-oxoethyl}phenyl 4-carbamimidamidobenzoate 59721-28-7 [RN] Benzeneacetic acid, 4-[[4-[(aminoiminomethyl)amino]benzoyl]oxy]-, 2-(dimethylamino)-2-oxoethyl ester Camostat Mesilate カモスタットメシル酸塩 日局収載 Trypsin-like protease inhibitor CAS 59721-29-8 C20H22N4O5.CH4O3S 494.52 MP 194, methanol, diethyl ether, Chemical and Pharmaceutical Bulletin, 2005, vol. 53, 8, pg. 893 – 898 カモスタットメシル酸塩 日局収載 Camostat Mesilate Dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)phenylacetate monomethanesulfonate C20H22N4O5▪CH4O3S : 494.52 [59721-29-8] Launched – 1985, in Japan …

Remdesivir, レムデシビル , ремдесивир , ريمديسيفير , 瑞德西韦 ,

It’s only fair to share…   Remdesivir Formula C27H35N6O8P CAS 1809249-37-3 Mol weight 602.576 レムデシビル UNII:3QKI37EEHE ремдесивир [Russian] [INN] ريمديسيفير [Arabic] [INN] 瑞德西韦 [Chinese] [INN] 2-Ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydro-2-furanyl]methoxy}(phenoxy)phosphoryl]amino}propanoate (non-preferred name) L-Alanine, N-((S)-hydroxyphenoxyphosphinyl)-, 2-ethylbutyl ester, 6-ester with 2-C-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-2,5-anhydro-D-altrononitrile 2-Ethylbutyl (2S)-2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate 2-Ethylbutyl (2S)-2-[[(S)-[[(2R,3S,4R,5R)-5-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy]phenoxyphosphoryl]amino]propanoate 2-Ethylbutyl (2S)-2-[[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy]phenoxyphosphoryl]amino]propanoate 2-Ethylbutyl N-[(S)-[2-C-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-2,5-anhydro-D-altrononitril-6-O-yl]phenoxyphosphoryl]-L-alaninate GS 5734 L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl)-, 2-ethylbutyl ester,6-ester with 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D-altrononitrile GS-5734 Treatment of viral infections Phase III, clinical trials for the treatment …